PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
August 18, 2010Heart89 citations

Long-term clinical outcome of extensive pulmonary vein isolation-based catheter ablation therapy in patients with paroxysmal and persistent atrial fibrillation

View Full Paper
SMShinsuke MiyazakiAKAtsushi KoboriYTYoshihide Takahashi

Key Result

Extensive pulmonary vein isolation-based catheter ablation maintained sinus rhythm without antiarrhythmic drugs in 83.6% of patients with paroxysmal or persistent AF at a mean of 27 months.

Study Design

Type

Cohort (n=574)

Structured PICO

Does an extensive pulmonary vein isolation-based catheter ablation strategy maintain long-term sinus rhythm in patients with drug-refractory paroxysmal or persistent atrial fibrillation?

P
Population
574 patients (mean age 61 years, 21.8% female) with drug-refractory paroxysmal or persistent atrial fibrillation undergoing catheter ablation, followed for a mean of 27 months.
E
Exposure
Extensive pulmonary vein isolation (EPVI)-based catheter ablation strategy (ipsilateral PV isolation with extensive antral ablation, cavotricuspid isthmus line, ablation of non-PV triggers, and left atrial linear ablation if needed).
O
Outcome
Maintenance of sinus rhythm without antiarrhythmic drugs at long-term follow-up.

Extensive pulmonary vein isolation-based catheter ablation is highly effective for long-term maintenance of sinus rhythm in drug-refractory AF, with very late recurrences primarily driven by non-PV triggers.

Abstract

OBJECTIVE: To examine the long-term clinical outcomes of patients undergoing catheter ablation (CA) for either paroxysmal (PAF) or persistent atrial fibrillation (PsAF) using an extensive pulmonary vein isolation (EPVI)-based strategy. METHODS AND RESULTS: 574 patients (61 ± 9 years; 449 men) with drug-refractory PAF or PsAF underwent CA. Ipsilateral pulmonary veins (PVs) were isolated with extensive antral ablation. A cavotricuspid isthmus line with bidirectional conduction block was created and all non-PV triggers of AF ablated at the index procedure. Left atrial linear ablation was performed in patients with PsAF if AF remained inducible. Patients with recurrent atrial arrhythmias had previous lesions assessed and consolidated. With mean follow up of 27 ± 14 months after the final procedure, 480 patients (83.6%) were in sinus rhythm without antiarrhythmic drugs (1.4 ± 0.6 procedures). The single procedure success rate without antiarrhythmic drugs was 65.5%. A late recurrence (>6 months after the initial procedure) and very late recurrence (>12 months) were seen in 1.6% and 1.7% of patients, respectively. All patients with a late recurrence had PV reconnection, with one patient also demonstrating a non-PV trigger. In comparison, non-PV triggers of AF accounted for 85.7% of very late recurrences with no evidence of PV reconduction. CONCLUSIONS: EPVI-based CA is effective in maintaining sinus rhythm in patients with PAF and PsAF over the long term. Recurrent AF after 1 year is mainly due to non-PV triggers, suggestive of an ongoing pathological process.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Miyazaki et al. (2010) conducted a cohort in paroxysmal and persistent atrial fibrillation (n=574). Extensive pulmonary vein isolation (EPVI)-based catheter ablation was evaluated on Sinus rhythm without antiarrhythmic drugs. Extensive pulmonary vein isolation-based catheter ablation maintained sinus rhythm without antiarrhythmic drugs in 83.6% of patients with paroxysmal or persistent AF at a mean of 27 months.

synapsesocial.com/papers/6a7ca1cb83cb829ce1c8957fhttps://doi.org/10.1136/hrt.2009.186874
Ask AI
Helpful
Bookmark
Share
View Full Paper